Quantcast
Home / Practice Areas / Business and Civil Practice / Wyeth accused of using sham patents to stop generic Effexor

Wyeth accused of using sham patents to stop generic Effexor

An antitrust lawsuit filed in federal court in Mississippi alleges that Wyeth Pharmaceuticals used fraudulently obtained patents as part of a scheme to delay the introduction of generic versions of the anti-depressant Effexor XR.